Nature9h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The American Journal of Managed Care17h
Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
Novo Nordisk will test CagriSema's long-term efficacy in late-stage trial, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
Kazia Therapeutics launches trial of paxalisib/immunotherapy combination
Kazia Therapeutics (KZIA) is pleased to announce the regulatory approval and launch of a clinical trial evaluating the combination of paxalisib ...
GlobalData on MSN23h
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.